Journal article
KEL1 negative red cell transfusions for females of current or future child‐bearing potential: A clinical impact and feasibility study
Abstract
BACKGROUND: Anti-K is an alloantibody stimulated in response to the KEL1 antigen and may cause hemolytic disease of the fetus and newborn (HDFN). Provision of KEL1 negative blood to females of child-bearing potential was not our practice. We assessed the impact of our policy and assessed feasibility of a KEL1 negative transfusion policy.
STUDY DESIGN AND METHODS: This is a cohort study spanning Jan 1, 2007-Jun 30, 2017 in Hamilton, Canada. Data …
Authors
Ning S; Morin P; Elahie A; Li N; Liu Y; Barty R; Clarke G; Zeller M; Heddle NM
Journal
Transfusion, Vol. 63, No. 1, pp. 59–68
Publisher
Wiley
Publication Date
January 2023
DOI
10.1111/trf.17201
ISSN
0041-1132